Literature DB >> 23917121

Prostate cancer: AUA-ASTRO guidelines for post-RP radiation fail to go nuclear.

Alberto Bossi, Alberto Briganti.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23917121     DOI： 10.1038/nrurol.2013.163

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  8 in total

1.  Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Bertrand Tombal; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Marc Colombel; Cees van de Beek; Paul Verhagen; Alphonsus van den Bergh; Cora Sternberg; Thomas Gasser; Geertjan van Tienhoven; Pierre Scalliet; Karin Haustermans; Laurence Collette
Journal:  Lancet       Date:  2012-10-19       Impact factor: 79.321

Review 2.  The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

Authors:  Maria Picchio; Alberto Briganti; Stefano Fanti; Axel Heidenreich; Bernd J Krause; Cristina Messa; Francesco Montorsi; Sven N Reske; George N Thalmann
Journal:  Eur Urol       Date:  2010-09-15       Impact factor: 20.096

3.  EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Authors:  Nicolas Mottet; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Hans-Peter Schmid; Theo Van der Kwast; Thomas Wiegel; Filiberto Zattoni; Axel Heidenreich
Journal:  Eur Urol       Date:  2011-01-25       Impact factor: 20.096

4.  Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.

Authors:  Alberto Briganti; Thomas Wiegel; Steven Joniau; Cesare Cozzarini; Marco Bianchi; Maxine Sun; Bertrand Tombal; Karin Haustermans; Tom Budiharto; Wolfgang Hinkelbein; Nadia Di Muzio; Pierre I Karakiewicz; Francesco Montorsi; Hein Van Poppel
Journal:  Eur Urol       Date:  2012-05-16       Impact factor: 20.096

5.  Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.

Authors:  Carol M Moinpour; Katherine A Hayden; Joseph M Unger; Ian M Thompson; Mary W Redman; Edith D Canby-Hagino; Betsy A Higgins; Jerry W Sullivan; Dianne Lemmon; Sheila Breslin; E David Crawford
Journal:  J Clin Oncol       Date:  2008-01-01       Impact factor: 44.544

6.  Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.

Authors:  Ian M Thompson; Richard K Valicenti; Peter Albertsen; Brian J Davis; S Larry Goldenberg; Carol Hahn; Eric Klein; Jeff Michalski; Mack Roach; Oliver Sartor; J Stuart Wolf; Martha M Faraday
Journal:  J Urol       Date:  2013-05-21       Impact factor: 7.450

7.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

8.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Authors:  Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith Canby-Hagino; E David Crawford
Journal:  J Urol       Date:  2009-01-23       Impact factor: 7.450
  8 in total
  1 in total

Review 1.  PSMA PET and Radionuclide Therapy in Prostate Cancer.

Authors:  Kirsten Bouchelouche; Baris Turkbey; Peter L Choyke
Journal:  Semin Nucl Med       Date:  2016-09-03       Impact factor: 4.446
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.